Vibrant nabs $7.5m Series E
Vibrant, a developer of gastrointestinal treatments, has secured $7.5 million in Series E funding.
Vibrant, a developer of gastrointestinal treatments, has secured $7.5 million in Series E funding.
Copyright PEI Media
Not for publication, email or dissemination